Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease

Progress in Lipid Research

Volumn 52, Issue 1, 2013, Pages 165-174

  Leamy, Alexandra K ^a   Egnatchik, Robert A ^a   Young, Jamey D ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Endoplasmic reticulum stress; Lipoapoptosis; Mitochondrial dysregulation; Oxidative stress; Phospholipid composition; Triglyceride synthesis

Indexed keywords

METFORMIN; PENTOXIFYLLINE; PIOGLITAZONE; PLACEBO; REACTIVE OXYGEN METABOLITE; SATURATED FATTY ACID; STRESS ACTIVATED PROTEIN KINASE; TRIACYLGLYCEROL;

APOPTOSIS; CELL FATE; CELL METABOLISM; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; ENDOPLASMIC RETICULUM STRESS; HUMAN; LIPOGENESIS; LIPOTOXICITY; MOLECULAR PATHOLOGY; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANIMALS; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; ENDOPLASMIC RETICULUM; FATTY ACIDS; FATTY LIVER; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TRIGLYCERIDES;

EID: 84872492049     PISSN: 01637827     EISSN: 18732194     Source Type: Journal    
DOI: 10.1016/j.plipres.2012.10.004     Document Type: Review

References (117)

1. N.J. Barshop, C.B. Sirlin, J.B. Schwimmer, and J.E. Lavine Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease Aliment Pharmacol Ther 28 2008 13 24
2. J.K. Reddy, and M.S. Rao Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation Am J Physiol Gastrointest Liver Physiol 290 2006 G852 G858
3. A. Feldstein, and G.J. Gores Steatohepatitis and apoptosis: therapeutic implications Am J Gastroenterol 99 2004 1718 1719
4. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
5. C.Z. Larter, and M.M. Yeh Animal models of NASH: getting both pathology and metabolic context right J Gastroenterol Hepatol 23 2008 1635 1648
6. I.A. Leclercq, G.C. Farrell, R. Schriemer, and G.R. Robertson Leptin is essential for the hepatic fibrogenic response to chronic liver injury J Hepatol 37 2002 206 213
7. A. Sahai, P. Malladi, X.M. Pan, R. Paul, H. Melin-Aldana, and R.M. Green Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin Am J Physiol Gastroint Liver Physiol 287 2004 G1035 G1043
8. S.Q. Yang, H.Z. Lin, M.D. Lane, M. Clemens, and A.M. Diehl Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis Proc Nat Ac Sci USA 94 1997 2557 2562
9. A. Sahai, P. Malladi, R.M. Green, and P.F. Whitington Steatohepatitis and liver fibrosis associated with upregulated osteopontin expression in diabetic/insulin-resistant db/db mice fed a methionine and choline deficient diet Hepatology 38 2003 497A
10. A. Dela Pena, I. Leclercq, J. Field, J. George, B. Jones, and G. Farrell NF-kappa B activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis Gastroenterology 129 2005 1663 1674
11. M.D. Weltman, G.C. Farrell, and C. Liddle Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation Gastroenterology 111 1996 1645 1653
12. A. Koteish, and A.M. Diehl Animal models of steatosis Semin Liver Dis 21 2001 89 104
13. M.E. Rinella, and R.M. Green The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance J Hepatol 40 2004 47 51
14. M.E. Visser, N.M. Lammers, A.J. Nederveen, M. van der Graaf, A. Heerschap, and M.T. Ackermans Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia Diabetologia 54 2011 2113 2121
15. A. Amaro, E. Fabbrini, M. Kars, P. Yue, K. Schechtman, and G. Schonfeld Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia Gastroenterology 139 2010 149 153
16. C.Z. Larter Not all models of fatty liver are created equal: understanding mechanisms of steatosis development is important J Gastroenterol Hepatol 22 2007 1353 1354
17. D.L. Gorden, P.T. Ivanova, D.S. Myers, J.O. McIntyre, M.N. VanSaun, and J.K. Wright Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model Plos One 6 2011
18. L. Listenberger, X. Han, S. Lewis, S. Cases, R. Farese, and D. Ory Triglyceride accumulation protects against fatty acid-induced lipotoxicity Proc Nat Ac Sci USA 100 2003 3077 3082
19. S. Hardy, W. El-Assaad, E. Przybytkowski, E. Joly, M. Prentki, and Y. Langelier Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells-A role for cardiolipin J Biol Chem 278 2003 31861 31870
20. S. Turpin, G. Lancaster, I. Darby, M. Febbraio, and M. Watt Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance Am J Physiol-Endocrinol Metab 291 2006 E1341 E1350
21. I. Okere, M. Chandler, T. McElfresh, J. Rennison, V. Sharov, and H. Sabbah Differential effects of saturated and unsaturated fatty acid diets on cardiomyocyte apoptosis, adipose distribution, and serum leptin Am J Physiol-Heart Circulatory Physiol 291 2006 H38 H44
22. S. Srivastava, and C. Chan Application of metabolic flux analysis to identify the mechanisms of free fatty acid toxicity to human hepatoma cell line Biotechnol Bioeng 99 2008 399 410
23. M. Pagliassotti, Y. Wei, and D. Wang Saturated fatty acids induce cytotoxicity in hepatocytes via effects on the endoplasmic reticulum Obesity Res 13 2005 A31
24. H. Malhi, and G.J. Gores Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease Semin Liver Dis 28 2008 360 369
25. S.M. Turpin, G.I. Lancaster, I. Darby, M.A. Febbraio, and M.J. Watt Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance Am J Physiol-Endocrinol Metab 291 2006 E1341 E1350
26. L.L. Listenberger, D.S. Ory, and J.E. Schaffer Palmitate-induced apoptosis can occur through a ceramide-independent pathway J Biol Chem 276 2001 14890 14895
27. L.L. Listenberger, X.L. Han, S.E. Lewis, S. Cases, R.V. Farese, and D.S. Ory Triglyceride accumulation protects against fatty acid-induced lipotoxicity Proc Nat Ac Sci USA 100 2003 3077 3082
28. Y. Noguchi, J.D. Young, J.O. Aleman, M.E. Hansen, J.K. Kelleher, and G. Stephanopoulos Effect of anaplerotic fluxes and amino acid availability on hepatic lipoapoptosis J Biol Chem 284 2009 33425 33436
29. R.J. Kaufman Orchestrating the unfolded protein response in health and disease J Clin Invest 110 2002 1389 1398
30. 2+: a control point for apoptosis Science 300 2003 135 139
31. R.C. Wek, and T.G. Anthony Obesity: stressing about unfolded proteins Nat Med 16 2010 374 376
32. D. Ron, and P. Walter Signal integration in the endoplasmic reticulum unfolded protein response Nat Rev Mol Cell Biol 8 2007 519 529
33. K.Z. Zhang, and R.J. Kaufman The unfolded protein response-a stress signaling pathway critical for health and disease Neurology 66 2006 S102 S109
34. U. Ozcan, Q. Cao, E. Yilmaz, A.H. Lee, N.N. Iwakoshi, and E. Ozdelen Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes Science 306 2004 457 461
35. 2+ close to IP(3)-sensitive channels that are sensed by neighboring mitochondria Science 262 1993 744 747
36. P. Bernardi Mitochondrial transport of cations: channels, exchangers, and permeability transition Physiol Rev 79 1999 1127 1155
37. M.F. Gregor, L. Yang, E. Fabbrini, B.S. Mohammed, J.C. Eagon, and G.S. Hotamisligil Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss Diabetes 58 2009 693 700
38. P. Puri, F. Mirshahi, O. Cheung, R. Natarajan, J.W. Maher, and J.M. Kellum Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease Gastroenterology 134 2008 568 576
39. N.K. Sharma, S.K. Das, A.K. Mondal, O.G. Hackney, W.S. Chu, and P.A. Kern Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects J Clin Endocrinol Metab 93 2008 4532 4541
40. D. Wang, Y.R. Wei, and M.J. Pagliassotti Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis Endocrinology 147 2006 943 951
41. Y. Wei, D. Wang, F. Topczewski, and M.J. Pagliassotti Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells Am J Physiol-Endocrinol Metab 291 2006 E275 E281
42. K.T. Pfaffenbach, C.L. Gentile, A.M. Nivala, D. Wang, Y.R. Wei, and M.J. Pagliassotti Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitate-mediated cell death Am J Physiol-Endocrinol Metab 298 2010 E1027 E1035
43. E. Diakogiannaki, H.J. Welters, and N.G. Morgan Differential regulation of the endoplasmic reticulum stress response in pancreatic beta-cells exposed to long-chain saturated and monounsaturated fatty acids J Endocrinol 197 2008 553 563
44. K. Thorn, and P. Bergsten Fatty acid-induced oxidation and triglyceride formation is higher in insulin-producing MIN6 cells exposed to oleate compared to palmitate J Cell Biochem 111 2010 497 507
45. W. Guo, S. Wong, W. Xie, T. Lei, and Z. Luo Palmitate modulates intracellular signaling, induces endoplasmic reticulum stress, and causes apoptosis in mouse 3T3-L1 and rat primary preadipocytes Am J Physiol-Endocrinol Metab 293 2007 E576 E586
46. N.M. Borradaile, X. Han, J.D. Harp, S.E. Gale, D.S. Ory, and J.E. Schaffer Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death J Lipid Res 47 2006 2726 2737
47. K. Pfaffenbach, C. Gentile, A. Nivala, D. Wang, Y. Wei, and M. Pagliassotti Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitate-mediated cell death Am J Physiol-Endocrinol Metab 298 2010 E1027 E1035
48. X. Gu, K. Li, D.R. Laybutt, M-l. He, H-L. Zhao, and J.C.N. Zhao Bip overexpression, but not CHOP inhibition, attenuates fatty-acid-induced endoplasmic reticulum stress and apoptosis in HepG2 liver cells Life Sci 87 2010 724 732
49. A.A. Spector, and M.A. Yorek Membrane lipid-composition and cellular function J Lipid Res 26 1985 1015 1035
50. J. Deguil, L. Pineau, E.C.R. Snyder, S. Dupont, L. Beney, and A. Gil Modulation of lipid-induced ER stress by fatty acid shape Traffic 12 2011 349 362
51. M.H.M. Van der Sanden, M. Houweling, L.M.G. Van Golde, and A.B. Vaandrager Inhibition of phosphatidylcholine synthesis induces expression of the endoplasmic reticulum stress and apoptosis-related protein CCAAT/enhancer- binding protein-homologous protein (CHOP/GADD153) Biochem J 369 2003 643 650
52. Y.K. Li, M.T. Ge, L. Ciani, G. Kuriakose, E.J. Westover, and M. Dura Enrichment of endoplasmic reticulum with cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2b activity in parallel with increased order of membrane lipids - Implications for depletion of endoplasmic reticulum calcium stores and apoptosis in cholesterol-loaded macrophages J Biol Chem 279 2004 37030 37039
53. H. Ariyama, N. Kono, S. Matsuda, T. Inoue, and H. Arai Decrease in membrane phospholipid unsaturation induces unfolded protein response J Biol Chem 285 2010 22027 22035
54. P. Puri, R.A. Baillie, M. Wiest, F. Mirshahi, and A.J. Sanyal A lipidomic analysis of non-alcoholic fatty liver disease (NAFLD) J Hepatol 44 2006 S260 S261
55. M.S. Han, S.Y. Park, K. Shinzawa, S. Kim, K.W. Chung, and J.-H. Lee Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes J Lipid Res 49 2008 84 97
56. K. Kakisaka, S.C. Cazanave, C.D. Fingas, M.E. Guicciardi, S.F. Bronk, and N.W. Werneburg Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis Am J Physiol Gastrointest Liver Physiol 302 2012 G77 G84
57. V. Adam-Vizi, and C. Chinopoulos Bioenergetics and the formation of mitochondrial reactive oxygen species Trends Pharmacol Sci 27 2006 639 645
58. P.S. Brookes, Y.S. Yoon, J.L. Robotham, M.W. Anders, and S.S. Sheu Calcium, ATP, and ROS: a mitochondrial love-hate triangle Am J Physiol-Cell Physiol 287 2004 C817 C833
59. N. Chalasani, M.A. Deeg, and D.W. Crabb Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis Am J Gastroenterol 99 2004 1497 1502
60. M.D. Weltman, G.C. Farrell, P. Hall, M. Ingelman-Sundberg, and C. Liddle Hepatic cytochrome p450 2E1 is increased in patients with nonalcoholic steatohepatitis Hepatology 27 1998 128 133
61. R.H. Lambertucci, S.M. Hirabara, L.D.R. Silveira, A.C. Levada-Pires, R. Curi, and T.C. Pithon-Curi Palmitate increases superoxide production through mitochondrial electron transport chain and NADPH oxidase activity in skeletal muscle cells J Cell Physiol 216 2008 796 804
62. S. Nakamura, T. Takamura, N. Matsuzawa-Nagata, H. Takayama, H. Misu, and H. Noda Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria J Biol Chem 284 2009 14809 14818
63. A.J. Sanyal, C. Morowitz, J. Clore, M.L. Shiffman, V.A. Luketic, and R. Sterling Nonalcoholic steatohepatitis (NASH) is associated with insulin resistance and mitochondrial structural abnormalities Gastroenterology 116 1999 A1271
64. A.J. Sanyal, C. Campbell-Sargent, F. Mirshahi, W.B. Rizzo, M.J. Contos, and R.K. Sterling Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 2001 1183 1192
65. P. Iozzo, M. Bucci, A. Roivainen, K. Nagren, M.J. Jaervisalo, and J. Kiss Fatty acid metabolism in the liver, measured by positron emission tomography is increased in obese individuals Gastroenterology 139 2010 846-U203
66. B.C. Weis, A.T. Cowan, N. Brown, D.W. Foster, and J.D. McGarry Use of a selective inhibitor of liver carnitine palmitoyltransferase-I (CPT-I) allows quantification if its contribution to total CPT-1 activity in rat-heat-Evidence that the dominant cardiac CPT-1 isoform is identical to the skeletal muscle enzyme J Biol Chem 269 1994 26443 26448
67. Y. Noguchi, J. Young, J. Aleman, M. Hansen, J. Kelleher, and G. Stephanopoulos Effect of anaplerotic fluxes and amino acid availability on hepatic lipoapoptosis J Biol Chem 284 2009 33425 33436
68. E. Ip, G.C. Farrell, G. Robertson, P. Hall, R. Kirsch, and I. Leclercq Central role of PPAR alpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice Hepatology 38 2003 123 132
69. S.-E. Choi, I.-R. Jung, Y.-J. Lee, S.-J. Lee, J.-H. Lee, and Y. Kim Stimulation of lipogenesis as well as fatty acid oxidation protects against palmitate-induced INS-1 beta-cell death Endocrinology 152 2011 816 827
70. N.E. Sunny, E.J. Parks, J.D. Browning, and S.C. Burgess Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease Cell Metab 14 2011 804 810
71. S. Satapati, N.E. Sunny, B. Kucejova, X.R. Fu, T.T. He, and A. Mendez-Lucas Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver J Lipid Res 53 2012 1080 1092
72. M. Perez-Carreras, P. Del Hoyo, M.A. Martin, J.C. Rubio, A. Martin, and G. Castellano Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis Hepatology 38 2003 999 1007
73. S.K. Mantena, D.P. Vaughn Jr., K.K. Andringa, H.B. Eccleston, A.L. King, and G.A. Abrams High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo Biochem J 417 2009 193
74. I. Garcia-Ruiz, C. Rodriguez-Juan, T. Diaz-Sanjuan, P. del Hoyo, F. Colina, and T. Munoz-Yague Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice Hepatology 44 2006 581 591
75. G. Serviddio, F. Bellanti, R. Tamborra, T. Rollo, A.D. Romano, and A.M. Giudetti Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model Eur J Clin Invest 38 2008 245 252
76. R. Singh, Y. Wang, Y. Xiang, K.E. Tanaka, W.A. Gaarde, and M.J. Czaja Differential Effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance Hepatology 49 2009 87 96
77. H. Malhi, S.F. Bronk, N.W. Werneburg, and G.J. Gores Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis J Biol Chem 281 2006 12093 12101
78. Y. Wang, L.M. Ausman, R.M. Russell, A.S. Greenberg, and X.-D. Wang Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax J Nutr 138 2008 1866 1871
79. R.J. Davis Signal transduction by the JNK group of MAP kinases Cell 103 2000 239 252
80. J.M. Schattenberg, R. Singh, Y.J. Wang, J.H. Lefkowitch, R.M. Rigoli, and P.E. Scherer JNK1 but not JNK2 promotes the development of steatohepatitis in mice Hepatology 43 2006 163 172
81. S.C. Cazanave, J.L. Mott, N.A. Elmi, S.F. Bronk, N.W. Werneburg, and Y. Akazawa JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis J Biol Chem 284 2009 26591 26602
82. K. Sabapathy, K. Hochedlinger, S.Y. Nam, A. Bauer, M. Karin, and E.F. Wagner Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation Mol Cell 15 2004 713 725
83. C.P. Day, and O.F.W. James Steatohepatitis: a tale of two "hits"? Gastroenterology 114 1998 842 845
84. J.E. Schaffer Lipotoxicity: when tissues overeat Cur Opin Lipidol 14 2003 281 287
85. M. Cnop, J.C. Hannaert, A. Hoorens, D.L. Eizirik, and D.G. Pipeleers Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation Diabetes 50 2001 1771 1777
86. M.D. Mantzaris, E.V. Tsianos, and D. Galaris Interruption of triacylglycerol synthesis in the endoplasmic reticulum is the initiating event for saturated fatty acid-induced lipotoxicity in liver cells Febs J 278 2011 519 530
87. Z.Z. Li, M. Berk, T.M. McIntyre, and A.E. Feldstein Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease-Role of stearoyl-CoA desaturase J Biol Chem 284 2009 5637 5644
88. H.G. Enoch, A. Catala, and P. Strittmatter Mechanism of rat-liver microsomal steroyl-CoA desaturase-Studies of substrate specificity, enzyme substrate interactions, and function of lipid J Biol Chem 251 1976 5095 5103
89. M. Miyazaki, W.C. Man, and J.M. Ntambi Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid J Nutr 131 2001 2260 2268
90. J.M. Ntambi, M. Miyazaki, J.P. Stoehr, H. Lan, C.M. Kendziorski, and B.S. Yandell Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity Proc Nat Ac Sci USA 99 2002 11482 11486
91. G. Rizki, L. Arnaboldi, B. Gabrielli, J. Yan, G.S. Lee, and R.K. Ng Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1 J Lipid Res 47 2006 2280 2290
92. K. Yamaguchi, L. Yang, S. McCall, J.W. Huang, X.X. Yu, and S.K. Pandey Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis Hepatology 45 2007 1366 1374
93. H. Chen, O. Charlat, L.A. Tartaglia, E.A. Woolf, X. Weng, and S.J. Ellis Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice Cell 84 1996 491 495
94. C.-L.E. Yen, S.J. Stone, S. Koliwad, C. Harris, and R.V. Farese Jr. DGAT enzymes and triacylglycerol biosynthesis J Lipid Res 49 2008 2283 2301
95. M. Monetti, M.C. Levin, M.J. Watt, M.P. Sajan, S. Marmor, and B.K. Hubbard Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver Cell Metab 6 2007 69 78
96. A.J. Sanyal, N. Chalasani, K.V. Kowdley, A. McCullough, A.M. Diehl, and N.M. Bass Pioglitazone, Vitamin E, or Placebo for nonalcoholic steatohepatitis New Eng J Med 362 2010 1675 1685
97. S.W.P. Koppe, A. Sahai, P. Malladi, P.F. Whitington, and R.M. Green Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet J Hepatol 41 2004 592 598
98. C.O. Zein, L.M. Yerian, P. Gogate, R. Lopez, J.P. Kirwan, and A.E. Feldstein Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial Hepatology 54 2011 1610 1619
99. V.B. Bhat, and K.M. Madyastha Antioxidant and radical scavenging properties of 8-oxo derivatives of xanthine drugs pentoxifylline and lisofylline Biochem Biophys Res Commun 288 2001 1212 1217
100. J.P. Freitas, and P.M. Filipe Pentoxifylline-A hydroxyl radical scavenger Biol Trace Elem Res 47 1995 307 311
101. L. Gomez-Cambronero, B. Camps, J.G. De la Asuncion, M. Cerda, A. Pellin, and F.V. Pallardo Pentoxifylline ameliorates cerulein-induced pancreatitis in rats: role of glutathione and nitric oxide J Pharmacol Exp Ther 293 2000 670 676
102. Y.D. Kim, K.-G. Park, Y.-S. Lee, Y.-Y. Park, D.-K. Kim, and B. Nedumaran Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP Diabetes 57 2008 306 314
103. C.A. Collier, C.R. Bruce, A.C. Smith, G. Lopaschuk, and D.J. Dyck Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle Am J Physiol-Endocrinol Metab 291 2006 E182 E189
104. R. Loomba, G. Lutchman, D.E. Kleiner, M. Ricks, J.J. Feld, and B.B. Borg Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis Alimentary Pharmacol Ther 29 2009 172 182
105. A.C. Tuyama, and C.Y. Chang Non-alcoholic fatty liver disease J Diabetes 4 2012 266 280
106. V. Nobili, M. Manco, R. Devito, V. Di Ciomm, D. Comparcola, and M.P. Sartorelh Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial Hepatology 48 2008 119 128
107. K. Promrat, D.E. Kleiner, H.M. Niemeier, E. Jackvony, M. Kearns, and J.R. Wands Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis Hepatology 51 2012 121 129
108. S.A. Harrison, W. Fecht, E.M. Brunt, and B.A. Neuschwander-Tetri Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial Hepatology 49 2009 80 86
109. J.M. Clark, A.R.A. Alkhuraishi, S.F. Solga, P. Alli, A.M. Diehl, and T.H. Magnuson Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease Obesity Res 13 2005 1180 1186
110. K.B. Barker, N.A. Palekar, S.P. Bowers, J.E. Goldberg, J.P. Pulcini, and S.A. Harrison Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery Am J Gastroenterol 101 2006 368 373
111. R.A. Weiner Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease Dig Dis 28 2010 274 279
112. C. Rabl, and G.M. Campos The impact of bariatric surgery on nonalcoholic steatohepatitis Semin Liver Dis 32 2012 80 92
113. N. Rafiq, and Z.M. Younossi Effects of weight loss on nonalcoholic fatty liver disease Semin Liver Dis 28 2008 427 433
114. Y. Miyazaki, A. Mahankali, M. Matsuda, S. Mahankali, J. Hardies, and K. Cusi Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients J Clin Endocrinol Metabol 87 2002 2784 2791
115. R. Belfort, S.A. Harrison, K. Brown, C. Darland, J. Finch, and J. Hardies A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis New Eng J Med 355 2006 2297 2307
116. A.K. Saha, P.R. Avilucea, J.M. Ye, M.M. Assifi, E.W. Kraegen, and N.B. Ruderman Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo Biochem Biophys Res Commun 314 2004 580 585
117. F. Abbasi, S.A. Chang, J.W. Chu, T.P. Ciaraldi, C. Lamendola, and T. McLaughlin Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes Am J Physiol-Regul Integ Comp Physiol 290 2006 R139 R144